Inés González‐Suarez

1.6k total citations
29 papers, 360 citations indexed

About

Inés González‐Suarez is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Inés González‐Suarez has authored 29 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 9 papers in Immunology and 7 papers in Neurology. Recurrent topics in Inés González‐Suarez's work include Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (6 papers) and Immune Cell Function and Interaction (3 papers). Inés González‐Suarez is often cited by papers focused on Multiple Sclerosis Research Studies (18 papers), Peripheral Neuropathies and Disorders (6 papers) and Immune Cell Function and Interaction (3 papers). Inés González‐Suarez collaborates with scholars based in Spain, Sweden and Portugal. Inés González‐Suarez's co-authors include Javier Arpa, Irene Sanz‐Gallego, Francisco Javier Rodríguez de Rivera Garrido, Cristina Fernández, Ángel Aledo‐Serrano, María L. Cuadrado, César Fernández‐de‐las‐Peñas, Celia Oreja‐Guevara, Jordi A. Matías‐Guiu and Juan José Ríos Blanco and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

Inés González‐Suarez

28 papers receiving 341 citations

Peers

Inés González‐Suarez
Wei Zhen Yeh Australia
Adrian Pace United Kingdom
John R. Rinker United States
Ai Muroi Japan
Inés González‐Suarez
Citations per year, relative to Inés González‐Suarez Inés González‐Suarez (= 1×) peers Frank Hoffmann

Countries citing papers authored by Inés González‐Suarez

Since Specialization
Citations

This map shows the geographic impact of Inés González‐Suarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inés González‐Suarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inés González‐Suarez more than expected).

Fields of papers citing papers by Inés González‐Suarez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inés González‐Suarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inés González‐Suarez. The network helps show where Inés González‐Suarez may publish in the future.

Co-authorship network of co-authors of Inés González‐Suarez

This figure shows the co-authorship network connecting the top 25 collaborators of Inés González‐Suarez. A scholar is included among the top collaborators of Inés González‐Suarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inés González‐Suarez. Inés González‐Suarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Álvarez, Elena, et al.. (2025). Beyond Efficacy: Persistence, NEDA, and Therapeutic Decision-Making in First-Line Multiple Sclerosis Treatment. Neurology and Therapy. 14(5). 2095–2106. 1 indexed citations
2.
Domínguez‐Mozo, María Inmaculada, Luisa María Villar, Lucienne Costa‐Frossard, et al.. (2025). Short‐chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile. Annals of Clinical and Translational Neurology. 12(3). 478–490.
3.
Oreja‐Guevara, Celia, et al.. (2024). Multiple sclerosis: Pregnancy, fertility, and assisted reproductive technology–a review. Multiple Sclerosis and Related Disorders. 92. 105893–105893. 2 indexed citations
4.
Silva, Ana, et al.. (2024). Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis. International Immunopharmacology. 131. 111826–111826. 3 indexed citations
5.
Gil‐Perotín, Sara, et al.. (2023). Reliability, validity and distribution of the Spanish female sexual function index in women with relapsing multiple sclerosis. BMC Women s Health. 23(1). 663–663. 2 indexed citations
6.
Domínguez‐Mozo, María Inmaculada, Inés González‐Suarez, Luisa María Villar, et al.. (2023). Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response. Frontiers in Immunology. 14. 1248182–1248182. 4 indexed citations
7.
González‐Suarez, Inés, et al.. (2023). Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.. Multiple Sclerosis and Related Disorders. 75. 104762–104762. 5 indexed citations
8.
9.
Álvarez, Elena, et al.. (2022). Development of a scale for the evaluation of the quality of the shared decision process in multiple sclerosis patients. PLoS ONE. 17(5). e0268125–e0268125. 1 indexed citations
10.
Silva, Ana, Rémi Cheynier, Patrí­cio Costa, et al.. (2022). Low Memory T Cells Blood Counts and High Naïve Regulatory T Cells Percentage at Relapsing Remitting Multiple Sclerosis Diagnosis. Frontiers in Immunology. 13. 901165–901165. 4 indexed citations
11.
Meca-Lallana, José, Francisco Pérez‐Miralles, María Sepúlveda, et al.. (2022). Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study. Neurology and Therapy. 11(3). 1101–1116. 13 indexed citations
12.
González‐Suarez, Inés, et al.. (2021). Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review. Multiple Sclerosis and Related Disorders. 49. 102783–102783. 14 indexed citations
13.
Meca-Lallana, José, Daniel Prefasi, Francisco Pérez‐Miralles, et al.. (2021). Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder. Patient Preference and Adherence. Volume 15. 713–719. 11 indexed citations
14.
Puertas, Inmaculada, et al.. (2020). Non-inflammatory causes of emergency consultation in patients with multiple sclerosis. SHILAP Revista de lepidopterología. 36(6). 403–411. 7 indexed citations
15.
Oreja‐Guevara, Celia, Ulises Gómez‐Pinedo, Rafael Sánchez‐Sánchez, et al.. (2017). Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis. Multiple Sclerosis and Related Disorders. 18. 71–76. 8 indexed citations
16.
Matías‐Guiu, Jordi A., et al.. (2016). Analysis of the Relationship between the Month of Birth and Risk of Multiple Sclerosis in a Spanish Population. European Neurology. 76(5-6). 202–209. 8 indexed citations
17.
González‐Suarez, Inés, Blanca Fuentes, Gerardo Ruiz‐Ares, Patricia Martínez‐Sánchez, & Exuperio Díez‐Tejedor. (2014). Varicella-zoster virus vasculopathy. A review description of a new case with multifocal brain hemorrhage. Journal of the Neurological Sciences. 338(1-2). 34–38. 15 indexed citations
18.
González‐Suarez, Inés, et al.. (2013). Leukoencephalopathy due to Oral Methotrexate. The Cerebellum. 13(1). 178–183. 17 indexed citations
19.
Ferrer, Elisa, et al.. (1994). Study of the retinal fiber layer in patients with acquired immunodeficiency syndrome.. PubMed. 3(1). 1–4. 6 indexed citations
20.
Fernández‐Garcia, Benjamín, Inés González‐Suarez, & A. Zapata. (1978). Ultrastructure of the filiform papillae on the tongue of the hamster.. Europe PMC (PubMed Central). 126(Pt 3). 487–94. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026